Previous studies have shown that the carcinogenic role MIF plays is related to the activation of p53, Ras/MAPK, and Akt pathways in the inflammation–cancer axis (Mittelbronn et al., 2011; Wang et al., 2017; Liu et al., 2018). This evidence concerns the gene MIF and cancer.